Steven Cohen's position in Ultragenyx Pharmaceutical is currently worth $42.6 Million. That's 0.13% of their equity portfolio (211th largest holding). The investor owns 1.15% of the outstanding Ultragenyx Pharmaceutical stock. The first Ultragenyx Pharmaceutical trade was made in Q1 2017. Since then Steven Cohen bought shares sixteen more times and sold shares on fifteen occasions. The investor's estimated purchase price is $68.9 Million, resulting in a loss of 38%.